Cardiac sarcoidosis: There is no instant replay

Chest

Volumn 128, Issue 1, 2005, Pages 3-6

  Judson, Marc A ^a,b  

^a Medical University of South Carolina ^*

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ECHOCARDIOGRAPHY; EDITORIAL; ELECTROCARDIOGRAM; HEART MUSCLE BIOPSY; HEART SARCOIDOSIS; NON INVASIVE MEASUREMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SARCOIDOSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 22244433497     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.128.1.3     Document Type: Editorial

References (30)

1. Sharma OP, Maheshwari A, Thaker K. Myocardial sarcoidosis. Chest 1993; 103:253-288
2. Silverman KJ, Hutchins GM, Bulkley BH. Cardiac sarcoid: a clinicopathological study of 84. unselected patients with systemic sarcoidosis. Circulation 1978; 58:1204-1211
3. Yazaki Y, Osobe M, Hiroe M, et al. Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone. Am J Cardiol 1001; 88:1006-1010
4. Fasano R, Rimmerman CM, Jaber WA. Cardiac sarcoidosis: a cause of infiltrative cardiomyopathy. Cleve Clin J Med 2004; 71:483-488
5. Desai MY, Fallert MA. Rapidly progressing congestive heart failure due to cardiac sarcoidosis involving papillary muscles: a case report and brief review of the literature. Cardiol Rev 2003; 11:163-168
6. Sekiguchi M, Yazaki Y, Isobe M, et al. Cardiac sarcoidosis: diagnostic, prognostic, and therapeutic considerations. Cardiovasc Drugs Ther 1996; 10:495-510
7. Chapelon-Abric C, de Zuttere D, DuHaut P, et al. Cardiac sarcoidosis: a retrospective study of 41 cases. Medicine (Baltimore) 2004; 83:315-334
8. Morales AR, Levy S, Davis J, et al. Sarcoidosis and the heart. Pathol Annu 1974; 9:139-155
9. Haraki T, Ueda K, Shintani H, et al. Spontaneous development of left ventricular aneurysm in a patient with untreated sarcoidosis. Circ J 2002; 66:519-521
10. Bagg SA, Gordon LL, Judson MA. Diagnostic yield of noninvasive tests for cardiac sarcoidosis [abstract]. Am J Respir Crit Care Med 2005; 171:A864
11. Kato Y, Morimoto S, Uemura A, et al. Efficacy of corticosteroids in sarcoidosis presenting with atrioventricular block. Sarcoid Vasc Diff Lung Dis 2003; 20:133-137
12. Larsen F, Pehrsson SK, Hammar N, et al. ECG abnormalities in Japanese and Swedish patients with sarcoidosis: a comparison. Sarcoid Vasc Diff Lung Dis 2001; 18:284-288
13. Boglioli LR, Taff ML, Funke S, et al. Sudden death due to sarcoid heart disease. J Forensic Sci 1998; 43:1072-1073
14. Huang CT, Heurich AE, Sutton AL, et al. Mortality in sarcoidosis: a changing pattern of the causes of death. Eur J Respir Dis 1981; 62:231-238
15. Uemura A, Morimoto S, Hiramitsu S, et al. Histologic diagnostic rate of cardiac sarcoidosis: evaluation of endomyocardial biopsies. Am Heart J 1999; 138:299-302
16. Umetani K, Ishihara T, Sawanobori T, et al. Successfully treated complete atrioventricular block with corticosteroid in a patient with cardiac sarcoidosis: usefulness of gallium-67 and thallium-201 scintigraphy. Intern Med 2000; 39:245-248
17. Resting Tl-201 scintigraphy in the evaluation of myocardial sarcoidosis. J Nucl Med 1997; 22:475-478
18. Barneveld PC, van Leeuwen C, van Isselt JW. Scintigraphic demonstration of myocardial sarcoidosis: the added value of single photon emission computed tomography. J Nucl Cardiol 1997; 4:256-257
19. 99mTc-sestamibi single-photon-emission scanning in the diagnosis of cardiac sarcoidosis. Chest 2004; 126:1372-1376
20. Doherty MJ, Kumar K, Nieholson AA, et al. Cardiac sarcoidosis: the value of magnetic resonance imagine in diagnosis and assessment of response to treatment. Respir Med 1998; 92:697-699
21. Shimada T, Shimada K, Sakane T, et al. Diagnosis of cardiac sarcoidosis and evaluation of the effects of steroid therapy by gadolinium-DPTA-enhanced magnetic resonance imaging. Am J Med 2001; 110:520-527
22. Vignaux O, Dhote R, Duboe D, et al. Clinical significance of myocardial magnetic resonance abnormalities in patients with sarcoidosis. Chest 2002; 122:1895-1901
23. Okumura W, Iwasaki T, Toyama T, et al. Usefulness of fasting 18F-FDG PET in identification of cardiac sarcoidosis. J Nucl Med 2004; 45:1989-1998
24. Kaminaga T, Takeshita T, Yamauchi T, et al. The role of iodine-123-labeled 15-(p-iodophenyl)-3R,S-methylpentadeconanoic acid scintigraphy in the detection of local myocardial involvement of sarcoidosis. Int J Cardiol 2004; 94:99-103
25. Hyodo E, Hozumi T, Takemoto Y, et al. Early detection of cardiac involvement in patients with sarcoidosis by a noninvasive method with ultrasonic tissue characterization. Heart 2004; 90:1275-1280
26. Hiraga H, Yuwai K, Hiroe M, et al. Guideline for the diagnosis of cardiac sarcoidosis: study report on diffuse pulmonary diseases [in Japanese]. Tokyo, Japan: Ministry of Health and Welfare, 1993; 23-24
27. Judson MA, Baughman RP, Teirstein AS, et al. Defining organ involvement in sarcoidosis: the ACCESS proposed instrument. Sarcoid Vasc Diffuse Lung Dis 1999; 16:75-86
28. Highland KB, Retalis P, Coppage L, et al. Is there an anatomical explanation for chest pain in patients with pulmonary sarcoidosis? South Med J 1997; 90:911-914
29. Hunninghake GW, Costabel U, Ando M, et al. Statement on sarcoidosis. Am J Respir Crit Care Med 1999; 160:736-755
30. Sharma OP. Myocardial sarcoidosis: a wolf in sheep's clothing. Chest 1994; 106:988-990